Canadian health-tech companies will benefit from access to user-defined clinical challenges, direct engagement with frontline clinicians, rigorous clinical trial design and execution, and real-world product evaluation. The goal is to ensure that new solutions are not only innovative, but also clinically validated, economically viable, and ready for scale within Canada’s health care system.